Abiopharma

New Form 6-K - So-Young International Inc. Filed: 2025-06-20 AccNo: 0001104659-25-060825 Size: 19 KB

New Form 10-K - Modular Medical, Inc. Filed: 2025-06-20 AccNo: 0001213900-25-055793 Size: 6 MB

New Form 8-K - Veradigm Inc. Filed: 2025-06-20 AccNo: 0001193125-25-143139 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits

New Form 8-K - Tharimmune, Inc. Filed: 2025-06-20 AccNo: 0001641172-25-015675 Size: 874 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 6-K - AC Immune SA Filed: 2025-06-20 AccNo: 0000950103-25-007642 Size: 11 MB

New Form 8-K - HARROW, INC. Filed: 2025-06-20 AccNo: 0001641172-25-015665 Size: 273 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 8-K - Annovis Bio, Inc. Filed: 2025-06-20 AccNo: 0001104659-25-060784 Size: 205 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form EFFECT - MANGOCEUTICALS, INC. Filed: 2025-06-18 AccNo: 9999999995-25-001956 Size: 1 KB

New Form EFFECT - Clearmind Medicine Inc. Filed: 2025-06-18 AccNo: 9999999995-25-001952 Size: 1 KB

New Form EFFECT - Ernexa Therapeutics Inc. Filed: 2025-06-18 AccNo: 9999999995-25-001964 Size: 2 KB

New Form 6-K - Addex Therapeutics Ltd. Filed: 2025-06-20 AccNo: 0001104659-25-060772 Size: 687 KB

New Form EFFECT - Oncology Institute, Inc. Filed: 2025-06-18 AccNo: 9999999995-25-001958 Size: 1 KB

New Form EFFECT - Aptevo Therapeutics Inc. Filed: 2025-06-18 AccNo: 9999999995-25-001965 Size: 1 KB

Linde Publishes 2024 Sustainable Development Report

General Announcement: USE OF PROCEEDS FROM THE RIGHTS ISSUE